Please assess the completion status of the following clinical trial:

Trial Title: Intrapartum Glycemic Control in GDMA2

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women 18 years or older~* Non-anomalous singleton gestation~* Gestational diabetes type A2 diagnosed at 24 weeks' gestation or beyond~* Planned vaginal delivery at term at Inova Fairfax Women's Hospital~Exclusion Criteria:~* Women \< 18 years~* Fetus with major congenital malformations~* Twin or higher order gestation~* Pre-existing diabetes mellitus~* Exposure to antenatal or any systemic steroids 14 days or less prior to delivery~* Preterm delivery~* Scheduled cesarean birth~* Intrapartum cesarean birth prior to 4-5 cm of cervical dilatation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Usual care glycemic management arm (Type: ACTIVE_COMPARATOR): Blood glucose will be checked every 2 hours during labor and glucose target will be 75-110 mg/dl
- More liberalized glycemic management arm (Type: ACTIVE_COMPARATOR): Blood glucose will be checked every 4 hours during labor and glucose target will be 70-126 mg/dl

Based on this trial design, predict the completion outcome and termination type (if applicable).